Okyo Pharma logo

Okyo Pharma Share Price Today

(NASDAQ: OKYO)

Okyo Pharma share price is $1.55 & ₹132.46 as on 26 Apr 2025, 2.30 'hrs' IST

$1.55

0.04

(2.51%)

Live

View live Okyo Pharma share price in Dollar and Rupees. Guide to invest in Okyo Pharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Okyo Pharma, along with analyst recommendations, forecasts, and comprehensive financials.

Okyo Pharma share price movements

  • Today's Low: $1.50
    Today's High: $1.58

    Day's Volatility :4.98%

  • 52 Weeks Low: $0.81
    52 Weeks High: $1.74

    52 Weeks Volatility :53.59%

Okyo Pharma (OKYO) Returns

PeriodOkyo Pharma LtdIndex (Russel 2000)
3 Months
43.97%
0.0%
6 Months
19.98%
0.0%
1 Year
4.49%
0.0%
3 Years
-58.24%
-9.5%

Okyo Pharma (OKYO) Key Statistics

in dollars & INR

Previous Close
$1.5117
Open
$1.5485
Today's High
$1.5786
Today's Low
$1.5
Market Capitalization
$50.9M
Today's Volume
$14.5K
52 Week High
$1.74
52 Week Low
$0.8075
Revenue TTM
$0.0
EBITDA
$-10.4M
Earnings Per Share (EPS)
$-0.38
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-2968.51%

How to invest in Okyo Pharma Stock (OKYO) from India?

It is very easy for Indian residents to invest directly in Okyo Pharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Okyo Pharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Okyo Pharma or OKYO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Okyo Pharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Okyo Pharma shares which would translate to 0.551 fractional shares of Okyo Pharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Okyo Pharma, in just a few clicks!

Returns in Okyo Pharma (OKYO) for Indian investors in Rupees

The Okyo Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Okyo Pharma investment value today

Current value as on today

₹1,09,472

Returns

₹9,472

(+9.47%)

Returns from Okyo Pharma Stock

₹6,897 (+6.9%)

Dollar Returns

₹2,575 (+2.58%)

Indian investors sentiment towards Okyo Pharma (OKYO)

-33%

Period: Mar 25, 2025 to Apr 24, 2025. Change in 30 Days versus previous period

Search interest for Okyo Pharma Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Okyo Pharma

  • Barclays PLC

    2.83%

  • Citadel Advisors Llc

    0.06%

  • Renaissance Technologies Corp

    0.05%

  • HPM Partners LLC

    0.04%

  • Geode Capital Management, LLC

    0.04%

  • UBS Group AG

    0.01%

Analyst Recommendation on Okyo Pharma

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Okyo Pharma(by analysts ranked 0 to 5 stars)

Analyst Forecast on Okyo Pharma Stock (OKYO)

What analysts predicted

Upside of 351.61%

Target:

$7.00

Current:

$1.55

Insights on Okyo Pharma Stock (Ticker Symbol: OKYO)

  • Price Movement

    In the last 7 days, OKYO stock has moved up by 23.9%
  • OKYO vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 72.4% return, outperforming this stock by 67.9%

Okyo Pharma Technicals Summary

Sell

Neutral

Buy

Okyo Pharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Okyo Pharma (OKYO) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Okyo Pharma Ltd logo
14.52%
19.98%
4.49%
-58.24%
-58.24%
Regeneron Pharmaceuticals, Inc. logo
-6.31%
-35.72%
-32.66%
-11.12%
9.54%
Beone Medicines Ltd logo
2.09%
20.37%
72.43%
67.9%
55.25%
Vertex Pharmaceuticals Incorporated logo
-1.56%
3.09%
23.83%
83.97%
83.41%
Alnylam Pharmaceuticals, Inc. logo
-9.88%
-14.83%
68.82%
56.52%
70.01%

About Okyo Pharma

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease; in phase 1 clinical trial for the treatment of neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. The company is also developing OK-201, which is in preclinical trial for the treatment of dry eye disease and neuropathic chronic pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Organization
Okyo Pharma
Employees
3
CEO
Dr. Gary S. Jacob Ph.D.
Industry
Miscellaneous

Management People of Okyo Pharma

NameTitle
Dr. Gary S. Jacob Ph.D.
CEO & Executive Director
Mr. Michael Paul Beck
Founder
Ms. Keeren Shah
Chief Financial Officer
Dr. Rajkumar Patil Ph.D.
Chief Scientific Officer

Important FAQs about investing in OKYO Stock from India :

What is Okyo Pharma share price today?

Okyo Pharma share price today stands at $1.55, Open: $1.54 ; Previous Close: $1.51 ; High: $1.58 ; Low: $1.50 ; 52 Week High: $1.74 ; 52 Week Low: $0.81.

The stock opens at $1.54, after a previous close of $1.51. The stock reached a daily high of $1.58 and a low of $1.50, with a 52-week high of $1.74 and a 52-week low of $0.81.

Can Indians buy Okyo Pharma shares?

Yes, Indians can invest in the Okyo Pharma (OKYO) from India.

With INDmoney, you can buy Okyo Pharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Okyo Pharma at zero transaction cost.

How can I buy Okyo Pharma shares from India?

It is very easy to buy Okyo Pharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Okyo Pharma (OKYO) be purchased?

Yes, you can buy fractional shares of Okyo Pharma with INDmoney app.

What are the documents required to start investing in Okyo Pharma stocks?

To start investing in Okyo Pharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Okyo Pharma Stock (OKYO)?

Today’s highest price of Okyo Pharma (OKYO) is $1.58.

Today’s lowest price of Okyo Pharma (OKYO) is $1.50.

What is today's market capitalisation of Okyo Pharma?

Today's market capitalisation of Okyo Pharma OKYO is 50.9M

What is the 52 Week High and Low Range of Okyo Pharma Stock (OKYO)?

  • 52 Week High

    $1.74

  • 52 Week Low

    $0.81

What are the historical returns of Okyo Pharma (OKYO)?

  • 1 Month Returns

    14.52%

  • 3 Months Returns

    19.98%

  • 1 Year Returns

    4.49%

  • 5 Years Returns

    -58.24%

Who is the Chief Executive Officer (CEO) of Okyo Pharma ?

Dr. Gary S. Jacob Ph.D. is the current Chief Executive Officer (CEO) of Okyo Pharma.